HOME › Research Insight › Major players, rat race, key playing fields and overall competitive landscape of Microfluidics Market
Major players, rat race, key playing fields and overall competitive landscape of Microfluidics Market
The global microfluidics market is a fragmented market with several major players and local players. Major players in the microfluidics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), Danaher Corporation (U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A majority of companies in the microfluidics market are from the U.S.
Among the growth strategies adopted by market players, agreements and collaborations accounted for a share of around 44%.These strategieswere adopted by players to enhance their product portfolio and technology integration and strengthen their market penetration in different geographies. Furthermore, players adopted these strategies to enhance their research work fordeveloping innovative products. The key players who adopted these strategies are Danaher Corporation (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Life Technologies Corporation (U.S.), and Becton Dickinson & Company (U.S.).Beckman Coulter, Inc., a Danaher Corporation company, received a new tri-source agreement from the U.S.-based Premier healthcare alliance, to continue to provide an entire range of laboratory platforms and supplies to Premier members. This agreement helped the company to achieve its financial targets.
New product launches isa key growth strategy adopted by players in order to strengthen their market presence and increase their share in the global market. The significant players that adopted this strategy include RainDance Technologies, Inc. (U.S.), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Cepheid (U.S.), Life Technologies Corporation (U.S.), Biofluidix GmbH (Germany), and Siemens Healthcare (Germany).Roche developed a novel Point-of-Care system namedthe Cobas b 101 system, for the diagnosis and management of metabolic syndrome. The launch enabled the company to strengthen its POC product portfolio.
The global microfluidics market is a highly fragmented market with no clear market leader. Apart from the major players, a number of small and medium sized players are adopting this technology, driven by the reduced cost, quick return on investments, and high profit margins offered by microfluidic technologies. Especially in countries such as China, India, and South Korea, the investments are heavily driven by the favorable economic conditions, and low labor and material costs.
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252